The NET Alliance™ and Novartis Oncology continue their commitment to improving knowledge and management of neuroendocrine tumors, and empowering patients to be more informed advocates.

  • А
  • А
  • А

Lung NET: A unique lung cancer

About 25% of neuroendocrine tumors (NET) originate in the bronchopulmonary system. These tumors include lung NET and thymic NET.29,30 Grade 1 and grade 2 lung NET are also referred to as typical and atypical carcinoid, respectively.31

  • Lung NET comprise approximately 2% of primary lung tumors.31 They are a distinct subset of NET that share common anatomic primary sites but represent a spectrum of different histologic diagnoses, clinical behaviors, and natural histories30
  • Thymic NET account for 2% of all mediastinal tumors.30 These tumors are usually sporadic,1,30 often more aggressive than other NET, and are associated with a less favorable prognosis30

Median 5-year survival is 27% for patients with well-differentiated lung NET with distant metastases.1

Click on the graphic to learn more about lung NET.

Animation to help you learn more about lung and thymic neuroendocrine tumors (NET)

Resource for Nurses: Take the NET Nurse Quiz! 

The NET Nurse Quiz is an interactive quiz to test your knowledge on neuroendocrine tumors and how the disease affects your patients.

Are you ready for the quiz?